Global Extracellular Matrix Patches Market Size (2024 - 2029)

The extracellular matrix patches market is anticipated to experience growth due to several key factors, including an increasing number of surgeries and the adoption of these patches in various surgical procedures such as hernia and pelvic reconstruction. The market's expansion is further supported by product launches and strategic initiatives by industry players. Despite the challenges posed by the COVID-19 pandemic, which led to a significant number of elective surgeries being postponed, the demand for extracellular matrix patches remains strong due to their critical role in supporting healing processes. However, the high cost of these patches may pose a barrier to market growth.

Market Size of Global Extracellular Matrix Patches Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Extracellular Matrix (ECM) Patches Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
CAGR 6.65 %
Fastest Growing Market Asia-Pacific
Largest Market North America

Major Players

Extracellular Matrix (ECM) Patches Market Major Players

*Disclaimer: Major Players sorted in no particular order

setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Extracellular Matrix Patches Market Analysis

The extracellular matrix patches market is projected to witness a CAGR of 6.65% over the forecast period (2022 - 2027).

COVID-19 had an unprecedented impact on the healthcare industry. Additionally, the restrictions imposed by governments across the world affected the number of surgeries performed. The recognition of the need to limit operative capacity to only emergent and/or urgent procedures resulted in delayed elective cardiac and vascular procedures and surgeries. The guidelines were set forth by national surgical and specialty societies. According to the study published in May 2020, "Elective surgery cancellations due to the COVID-19 pandemic: global predictive modeling to inform surgical recovery plans" based on 12 weeks of peak disruption to hospital services due to COVID-19, around 28.4 million elective surgeries worldwide were canceled or postponed in 2020. More than 580,000 planned surgeries in India were canceled or delayed as a result of the COVID-19 pandemic. Such cancellation of surgeries affected the growth of the market as extracellular matrix patches are largely employed in reconstruction, soft tissue, and vascular surgeries. Thus, COVID-19 had a pronounced impact on the growth of the market.

The major factors such as the increasing number of surgeries, adoption of extracellular matrix patches in hernia and pelvic reconstruction surgeries, product launches, and strategic initiatives by market players are driving the growth of the market.

The increasing number of surgeries is one of the major factors propelling the growth, as an extracellular matrix patch is a surgical mesh that fosters healing. Thus, a higher number of surgeries being performed worldwide is expected to propel the growth of the market. For instance, as per a September 2020 published article titled "Estimation of the National Surgical Needs in India by Enumerating the Surgical Procedures in an Urban Community Under Universal Health Coverage," an estimated 5,000 surgeries are required to meet the surgical burden of diseases of 100,000 people in low- and middle-income countries (LMICs). Additionally, as per the same source, the reported rates of surgery vary from 295 in low-and middle-income countries (LMICs) to 23,000 in high-income countries (HIC) per 100,000 population. Likewise, according to the Center for Disease Control and Prevention's 2022 update, a total of 18.2 million adults had coronary artery disease, and approximately 70% of these patients underwent surgery. Such a high burden of surgeries creates a need for ECM patches as such surgeries also employ them to support the healing process, thus boosting the growth of the market.

Additionally, the companies are focusing on developing an extracellular matrix for soft tissue repair. For instance, in February 2020, Aroa Biosurgery launched Myriad, a new product for soft tissue repair and reconstruction, in the United States market. Myriad can be used for a variety of plastic and reconstructive surgical operations that require the repair or reinforcement of soft tissue, including plastic surgery, limb salvage, burns, and trauma.

Furthermore, the strategic initiatives taken by the market players are also expected to boost the growth of the market. For instance, in July 2021, Becton, Dickinson, and Company acquired Tepha, Inc. Tepha is one of the leading developers and manufacturers of proprietary resorbable polymer technology. Such acquisitions also contribute to the growth of the market.

Thus, owing to the abovementioned factors, the market is expected to project growth over the forecast period. However, the high cost of extracellular matrix patch grafts may impede the growth of the market.

Extracellular Matrix Patches Industry Segmentation

As per the scope of the report, the extracellular matrix patches are a 3D network consisting of extracellular macromolecules that are used to provide support to the surrounding cells. It promotes a regenerative or healing pathway and facilitates tissue remodeling. It is used to support tissues segregating one another and to regulate intercellular communication. The Global Extracellular Matrix Patches Market by raw material (Porcine, Bovine, and Others), application (Soft Tissue Repair, Cardiac Repair, Vascular Repair, and Reconstruction, and Others), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Raw Material
Porcine
Bovine
Others
By Application
Soft Tissue Repair
Cardiac Repair
Vascular Repair & Reconstruction
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Global Extracellular Matrix Patches Market Size Summary

The extracellular matrix patches market is poised for growth, driven by an increasing number of surgeries and the adoption of these patches in various medical procedures. The market's expansion is supported by the rising demand for surgical meshes that aid in healing, particularly in hernia and pelvic reconstruction surgeries. Product launches and strategic initiatives by key market players further bolster this growth. Despite the challenges posed by the COVID-19 pandemic, which led to a significant number of elective surgeries being postponed, the market is expected to recover and continue its upward trajectory. The development of new products, such as Aroa Biosurgery's Myriad for soft tissue repair, and strategic acquisitions, like Becton, Dickinson, and Company's acquisition of Tepha, Inc., are contributing to the market's dynamic landscape.

The cardiac repair segment is anticipated to hold a substantial share of the market, driven by the prevalence of cardiovascular diseases and the ongoing development of innovative products. The increasing focus on research and development, along with regulatory approvals, is expected to enhance the segment's growth. North America is projected to witness significant market growth due to the rising incidence of cardiovascular conditions, sports injuries, and hernia disorders, coupled with a growing geriatric population. The market's competitive nature is characterized by the presence of major players employing strategies such as product launches, expansions, and acquisitions to strengthen their market positions. Key players include Baxter International, Coloplast, MTF Biologics, Terumo Corporation, and Aziyo Biologics, among others.

Explore More

Global Extracellular Matrix Patches Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Number of Surgeries

      2. 1.2.2 Adoption of Extracellular Matrix Patch in Hernia and Pelvic Reconstruction Surgeries

    3. 1.3 Market Restraints

      1. 1.3.1 High Cost of Extracellular Matrix Patch Procedure

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 2.1 By Raw Material

      1. 2.1.1 Porcine

      2. 2.1.2 Bovine

      3. 2.1.3 Others

    2. 2.2 By Application

      1. 2.2.1 Soft Tissue Repair

      2. 2.2.2 Cardiac Repair

      3. 2.2.3 Vascular Repair & Reconstruction

      4. 2.2.4 Others

    3. 2.3 Geography

      1. 2.3.1 North America

        1. 2.3.1.1 United States

        2. 2.3.1.2 Canada

        3. 2.3.1.3 Mexico

      2. 2.3.2 Europe

        1. 2.3.2.1 Germany

        2. 2.3.2.2 United Kingdom

        3. 2.3.2.3 France

        4. 2.3.2.4 Italy

        5. 2.3.2.5 Spain

        6. 2.3.2.6 Rest of Europe

      3. 2.3.3 Asia-Pacific

        1. 2.3.3.1 China

        2. 2.3.3.2 Japan

        3. 2.3.3.3 India

        4. 2.3.3.4 Australia

        5. 2.3.3.5 South Korea

        6. 2.3.3.6 Rest of Asia-Pacific

      4. 2.3.4 Middle East and Africa

        1. 2.3.4.1 GCC

        2. 2.3.4.2 South Africa

        3. 2.3.4.3 Rest of Middle East and Africa

      5. 2.3.5 South America

        1. 2.3.5.1 Brazil

        2. 2.3.5.2 Argentina

        3. 2.3.5.3 Rest of South America

Global Extracellular Matrix Patches Market Size FAQs

The Global Extracellular Matrix Patches Market is projected to register a CAGR of 6.65% during the forecast period (2024-2029)

Baxter International, Terumo Corporation, Aziyo Biologics, Coloplast and MTF Biologics are the major companies operating in the Global Extracellular Matrix Patches Market.

Extracellular Matrix Patches Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)